Form 4 for ASTH Astrana Health, Inc.
Accepted 2024-11-20 00:00:00 ET · period of report 2024-11-18 · accession 0001104659-24-121024 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-20 | 2024-11-18 | ASTH | Sim Kenneth T. | Executive COB, Dir | M - OptEx | $18.65 | +28.0K | 609.9K | +5% | +$523.1K |
| D | 2024-11-20 | 2024-11-18 | ASTH | Sim Kenneth T. | Executive COB, Dir | M - OptEx | $0.00 | -28.0K | 0 | -100% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-18 | M | A | 28,046 | $18.65 | 609,905 | D | — | — | (F6) Includes 290,000 shares of restricted stock, which will vest as follows (in each case subject to continuous employment with the Issuer): (i) 96,667 shares, which will vest in four equal annual installments beginning in the first quarter of 2025; and (ii) grants of 30,000 shares, 30,000 shares and 133,333 shares, each of which will vest upon achievement of certain pre-established performance goals. |
| 2 | Derivative | Stock option (right to buy) | 2024-11-18 | M | D | 28,046 | $0.00 | 0 | D | $18.65 · — to 2024-12-30 | 28,046 Common Stock | (F5) These stock options were fully vested and exercisable. |